Bafna Pharmaceuticals Complete Financial Statements
BAFNAPH • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2020 - 2015
Complete Financial Data Export
Export complete financial statements for Bafna Pharmaceuticals (BAFNAPH).
Downloads include all available records across all periods.
For market performance, see the
BAFNAPH stock price today
.
Profitability Ratios
Net Profit Margin
-8.33%
2019 data
Operating Margin
-3.00%
2019 data
Return on Assets
-1.41%
2019 data
Return on Equity
-1.96%
2019 data
Balance Sheet Ratios
Current Ratio
12.00
2019 data
Debt to Equity
1.39
2019 data
Equity Ratio
71.83%
2019 data
Asset Turnover
0.17
2019 data
Year-over-Year Growth Analysis
Comparing Sept 2018 vs Sept 2019
Revenue Growth
+33.3%
Year-over-Year
Expense Growth
+33.3%
Year-over-Year
Assets Growth
-40.8%
Year-over-Year
Equity Growth
+168.4%
Year-over-Year
Liabilities Growth
-40.8%
Year-over-Year
Operating Cash Flow Growth
-1600.0%
Year-over-Year
Investing Cash Flow Growth
+120.0%
Year-over-Year
Financing Cash Flow Growth
+150.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2019 | Jun 2019 | Sept 2018 | Jun 2018 |
|---|---|---|---|---|
| Revenue | 12 | 7 | 9 | 12 |
| Expenses | 12 | 10 | 9 | 14 |
| EBITDA | 0 | -3 | 0 | -2 |
| Operating Profit Margin % | -3.00% | -42.00% | 2.00% | -15.00% |
| Depreciation | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 |
| Profit Before Tax | -1 | -4 | -1 | -4 |
| Tax | 0 | -2 | 0 | 0 |
| Net Profit | -1 | -2 | -1 | -4 |
| Earnings Per Share (₹) | -0.25 | -0.90 | -0.80 | 0.00 |
Related Pages for Bafna Pharmaceuticals
Additional stock information and data for BAFNAPH
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 71 | 120 | 138 | 178 | 193 | 200 |
| Current Assets | 36 | 49 | 49 | 77 | 123 | 127 |
| Fixed Assets | 35 | 37 | 45 | 49 | 53 | 55 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 17 | 0 | 0 |
| Other Assets | 36 | 82 | 94 | 113 | 140 | 145 |
| LIABILITIES | ||||||
| Total Liabilities | 71 | 120 | 138 | 178 | 193 | 200 |
| Current Liabilities | 3 | 30 | 41 | 55 | 40 | 16 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 51 | 19 | 37 | 42 | 58 | 73 |
| Share Capital | 2 | 24 | 24 | 19 | 19 | 19 |
| Reserves & Surplus | -7 | -5 | 14 | 20 | 39 | 53 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|
| Operating Activities | -34 | -2 | -7 | -1 | 1 | 11 |
| Investing Activities | 33 | 15 | 38 | -5 | 0 | 60 |
| Financing Activities | 7 | -14 | -31 | 6 | -1 | -71 |
| Net Cash Flow | 6 | 0 | 0 | 0 | 0 | 0 |